Data / Form D filings / AsclepiX Therapeutics, Inc.
AsclepiX Therapeutics, Inc.: Form D filings
AsclepiX Therapeutics, Inc., a biotechnology company in Bethesda, MD, filed 5 Form D notices with the SEC between 2017 and 2024. The latest, on April 26, 2024, reports $10 million sold of a $12.5 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5237 River Road, #334, Bethesda, MD, 20816
- Phone
- (610) 212-1217
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1697751
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 26, 2024 | New notice | $12,544,498 | $10,044,498 | $2,500,000 | 9 | Jul 19, 2023 | sec.gov |
| Jun 11, 2020 | New notice | $35,000,000 | $10,000,000 | $25,000,000 | 34 | May 27, 2020 | sec.gov |
| Jun 17, 2019 | Amendment | $10,000,000 | $7,735,500 | $2,264,500 | 26 | Oct 12, 2018 | sec.gov |
| Oct 25, 2018 | New notice | $7,500,000 | $3,877,000 | $3,623,000 | 15 | Oct 12, 2018 | sec.gov |
| Feb 9, 2017 | New notice | $1,000,000 | $175,000 | $825,000 | 5 | Feb 3, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Dempsey | Executive Officer | |
| Steven Altschuler | Director | |
| Ben Askew | Director | |
| Josh Barer | Director | |
| Chris Garabedian | Director | |
| Aleksander Popel | Executive Officer | |
| Sapna Srivastava | Director | |
| Amir Shojaei | Executive Officer | |
| Niranjan Pandey | Executive Officer | |
| Jill Tierney | Executive Officer | |
| Jordan Green | Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Apr 22, 2024 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AsclepiX Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.